Better Therapeutics, Inc.
BTTX
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 22.76% | 18.89% | -6.75% | 23.15% | -14.88% |
| Total Depreciation and Amortization | 5.52% | 5.56% | 138.62% | -381.70% | 6.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.67% | 16.59% | -8.69% | -26.15% | 51.62% |
| Change in Net Operating Assets | -209.94% | 334.16% | -141.65% | -59.30% | 43.77% |
| Cash from Operations | -16.83% | 41.64% | -37.54% | 9.63% | -4.25% |
| Capital Expenditure | -- | 100.00% | -85.71% | 39.13% | 23.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.12% | -1.62% | -43.06% | 1.42% | 6.90% |
| Cash from Investing | 113.12% | 3.45% | -44.72% | 3.74% | 8.11% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | 2.76% | -- | -- | -- |
| Issuance of Common Stock | 2.78% | -- | -- | 2,100.00% | -95.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.00% | -- | -- | -- | -- |
| Cash from Financing | 9.81% | 1,414.48% | -429.55% | 2,100.00% | -99.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.06% | 101.32% | -47.33% | 11.04% | -271.23% |